Digg It
#1 in Business Subscribe Email Print

You are here: Home > Business > Marketing > Questioning the Data of Demographic Off The Shelf Marketing Products

Tags

  • drugs
  • which
  • product
  • biological product
  • companies involved

  • Links

  • Wedding Speech Technique
  • 8 Ways to Overcome Your Fears of Outsourcing
  • The Outlook on HDTV Ready LCD
  • Digg It - Questioning the Data of Demographic Off The Shelf Marketing Products

    I have been working on a direct mail campaign for our team in many areas and we are finding that the yellow page listings
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    and business list CDROMS contain so many closed companies that we are spending too much on the mailings which are opened
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    a little less because of the anthrax scare. Even customized lists are of little value. No one is keeping these lists fre
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    sh and deleting the ole data. Book of Lists are outdated as soon as they come out, CDROMS rip people off by disallowing l
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    ts of search downloads, yellow pages forget it. Phone numbers are wrong, addresses are wrong as a matter of fact most bus
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    iness parks are 30% unoccupied, downtowns about 15% and industrial areas about 28% nationwide, so with all these jobs and
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    companies gone, there is no one keeping track of the data. Yet we are told the recession is over? Whatever. Are we judgi
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    ng by the stock market? Because it is not real either.

    The NASDAQ de-listed any company that might bring the market down
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    over the last year and a half, except right after 9-11. It is a gambling casino anyway and the market always leads the re
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    al economy by 6 months. So if the market is just now going back up from its 9-11 average then we still have 6 months to g
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    et back to where we were then, which was terrible, remember all the lay offs before 9-11, starting back this time last ye
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    ar? Companies sell us lists all the time, the lists are wrong and rather than change the lists and update, they sell us o
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    d data and say we do not have the staff to fix the data more than once a year. Yet it needs to be changed every three mon
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    ths to even be + - 15% real. Yet if your Direct mail nets you only 1% we are really hurting. Direct Mail also termed junk
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    mail is what pays for over 75% of the US Mail budget.

    So if we lose the direct mail marketing technique we also raise o
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    ur postal rates by that same percentage. Less mail means even higher prices. Big problems, since this is a major us infra
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    tructure we need to keep civilization strong in America. If we replace the mail with e-mail then we will get tons of junk
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    e-mail. Then important e-mails will be buried in 300 e-mails a day. Why doesn’t the FTC look into the list makers and th
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    eir advertising, they are way off when they tell you that their data bases are updated and are (+) (-) 2%. Small business
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    es are being hurt and that hurts America, since 2/3 rds of Americans are employed by small business and not by government


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.diggit.org.ua/article/29708/diggit-Questioning-the-Data-of-Demographic-Off-The-Shelf-Marketing-Products.html">Questioning the Data of Demographic Off The Shelf Marketing Products</a>

    BB link (for phorums):
    [url=http://www.diggit.org.ua/article/29708/diggit-Questioning-the-Data-of-Demographic-Off-The-Shelf-Marketing-Products.html]Questioning the Data of Demographic Off The Shelf Marketing Products[/url]

    Related Articles:

    How BPM Improves CRM

    Differentiating Yourself from the Competition

    Using Hypnosis For Career Development

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com